谷歌浏览器插件
订阅小程序
在清言上使用

Patients (pts) with Recurrent And/or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN) Treated with Nivolumab (NIVO) in the First-Line (1L) or Later-Line (2L+) Settings in Germany: Updated Results from the Real-World HANNA Study

ANNALS OF ONCOLOGY(2023)

引用 0|浏览16
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要